Cellular and Molecular Aspects of Myeloproliferative Neoplasms - Part B
- 1st Edition, Volume 366 - February 11, 2022
- Latest edition
- Editors: Niccolo Bartalucci, Lorenzo Galluzzi
- Language: English
Cellular and Molecular Aspects of Myeloproliferative Neoplasms - Part B, Volume 366 in the International Review of Cell and Molecular Biology series, highlights new advances in t… Read more
Cellular and Molecular Aspects of Myeloproliferative Neoplasms - Part B, Volume 366 in the International Review of Cell and Molecular Biology series, highlights new advances in the field, with this new volume presenting interesting chapters written by an international board of authors. Sections cover Genetic and Sex predisposition to MPN, Transcriptional configurations of Myeloproliferative Neoplasms, Inhibitors and therapeutic targets of MPN, Mutational landscape of blast-phase myeloproliferative neoplasm (MPN-BP) and antecedent MPN, and Lessons from Mouse model of MPN, Lab tests for MPN.
- Publishes only invited review articles on selected topics
- Authored by established and active cell and molecular biologists from international sources
- Offers a wide range of perspectives on specific subjects
Academic, government and industrial sectors
Preface
Lorenzo Galluzzi and Niccolò Bartalucci
1. The roles of sex and genetics in the MPN
Alison R. Moliterno and Evan M. Braunstein
2. Transcriptional configurations of myeloproliferative neoplasms
Fiorella Schischlik
3. Therapeutic targets in MPN and related inhibitors
Gabriel Levy, Cristina Mambet, Christian Pecquet, Sarah Bailly, Violaine Havelange, Carmen C. Diaconu and Stefan N. Constantinescu
4. Mutational landscape of blast phase myeloproliferative neoplasms (MPN-BP) and antecedent MPN
Sergiu Pasca, Helen T. Chifotides, Srdan Verstovsek and Prithviraj Bose
5. Lessons from mouse models of MPN
Camelia Benlabiod, Tracy Dagher, Caroline Marty and Jean-Luc Villeval
6. Lab tests for MPN
Alice Moncada and Alessandro Pancrazzi
- Edition: 1
- Latest edition
- Volume: 366
- Published: February 11, 2022
- Language: English
NB
Niccolo Bartalucci
Niccolo Bartalucci practices in Florence, Italy. Dr. Bartalucci is highly rated in 6 conditions, according to our data. His top areas of expertise are Essential Thrombocythemia, Myelofibrosis, Polycythemia Vera, and Splenomegaly. His clinical research consists of co-authoring 34 peer reviewed articles in the past 15 years.
Affiliations and expertise
Department of Experimental and Clinical Medicine, University of Florence, ItalyLG
Lorenzo Galluzzi
Lorenzo Galluzzi is Assistant Professor of Cell Biology in Radiation Oncology at the Department of Radiation Oncology of the Weill Cornell Medical College, Honorary Assistant Professor Adjunct with the Department of Dermatology of the Yale School of Medicine, Honorary Associate Professor with the Faculty of Medicine of the University of Paris, and Faculty Member with the Graduate School of Biomedical Sciences and Biotechnology of the University of Ferrara, the Graduate School of Pharmacological Sciences of the University of Padova, and the Graduate School of Network Oncology and Precision Medicine of the University of Rome “La Sapienza”. Moreover, he is Associate Director of the European Academy for Tumor Immunology and Founding Member of the European Research Institute for Integrated Cellular Pathology.
Galluzzi is best known for major experimental and conceptual contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology. He has published over 450 articles in international peer-reviewed journals and is the Editor-in-Chief of four journals:
OncoImmunology (which he co-founded in 2011), International Review of Cell and Molecular Biology, Methods in Cell biology, and Molecular and Cellular Oncology (which he co-founded in 2013). Additionally, he serves as Founding Editor for Microbial Cell and Cell Stress, and Associate Editor for Cell Death and Disease, Pharmacological Research and iScience.
Affiliations and expertise
Assistant Professor of Cell Biology in Radiation Oncology, Department of Radiation Oncology, Weill Cornell Medical College, NY, USARead Cellular and Molecular Aspects of Myeloproliferative Neoplasms - Part B on ScienceDirect